Marlyn Jean (Krampitz) Mayo MD
Hepatology & Liver Transplantation
Professor of Medicine, University Tex SW Dallas
Join to view full profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-0595
Fax+1 214-645-0596
Dr. Mayo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Gastroenterology, 1993 - 1996
University of California (Irvine)Residency, Internal Medicine, 1990 - 1993
Baylor College of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1992 - Present
TX State Medical License 1992 - 2028
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
Publications & Presentations
PubMed
- Elafibranor in primary biliary cholangitis: Two-year placebo-controlled outcomes and long-term open-label data from the ELATIVE® phase III trial.Kris V Kowdley, Christopher L Bowlus, Cynthia Levy, Ulus Akarca, Mario Reis Alvares-da-Silva
Journal of Hepatology. 2026-08-27 - Cholestatic Pruritus: A Review of Pathophysiology, Clinical Manifestations, and Therapeutic Landscape.Ehiamen T Okoruwa, Marlyn J Mayo
Clinics in Liver Disease. 2026-08-01 - 3 citationsSeladelpar Improved Itch, Itch-Related Sleep Disturbance and Measures of Fatigue in Patients With Primary Biliary Cholangitis and Pruritus in the Phase 3 RESPONSE Trial.Cynthia Levy, David E J Jones, Marlyn J Mayo, Christopher L Bowlus, Kris V Kowdley
Alimentary Pharmacology & Therapeutics. 2026-07-01
Journal Articles
- Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver DiseasesMarlyn (Krampitz) Mayo, MD, Hepatology
Authored Content
- The Liver Meeting's Highlights and LowlightsNovember 2023
Press Mentions
Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation with Data from LIVMARLI® and Volixibat Clinical Programs at AASLD’s the Liver Meeting®November 7th, 2025- Seladelpar Reduces Pruritus Measures in Primary Biliary CholangitisNovember 6th, 2025
- Pioneering Discussions at IISLD 2024: Advancing Treatment for PBC and Alpha-1 Antitrypsin DeficiencyOctober 11th, 2024
Grant Support
- Ursodeoxycholic Acid (UDCA) In Primary Biliary CirrhosisNational Center For Research Resources2007
- UDCA Amp;Methotrexate For Primary Biliary CirrhosisNational Center For Research Resources2007
- Treatment Of Metabolic PruritisNational Center For Research Resources2004–2007
- UDCA &Methotrexate For Primary Biliary CirrhosisNational Center For Research Resources2006
- Longitudinal Studies Of Primary Biliary CirrhosisNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
Committees
- Member, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD) 2016 - Present
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: